Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2- aminopropane (DOM), ketanserin, and (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2- (4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 2, 2009, Pages 671-679

  Li, Jun Xu ^a   Unzeitig, Alison ^a   Javors, Martin A ^a   Rice, Kenner C ^b   Koek, Wouter ^a   France, Charles P ^a  

^a University of Texas Health Science Center   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; ALPHA 1 ADRENERGIC RECEPTOR; FENCLONINE METHYL ESTER; FENFLURAMINE; KETAMINE; KETANSERIN TARTRATE; MORPHINE; PHENCYCLIDINE; PRAZOSIN; RITANSERIN; SEROTONIN 2A RECEPTOR; SODIUM CHLORIDE; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESPONSE; INVERSE AGONISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

2,5-DIMETHOXY-4-METHYLAMPHETAMINE; ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FLUOROBENZENES; KETAMINE; KETANSERIN; MALE; MORPHINE; PHENCYCLIDINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA-1; RITANSERIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 70350436284     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.157560     Document Type: Article

References (37)

1. 2 receptors. Neuropharmacology 32:1427-1432.
2. 2C receptors. Pharmacol Ther 121:160-173.
3. Ariens EJ (1954) Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory. Arch Int Pharmacodyn Ther 99:32-49.
4. Barker EL, Westphal RS, Schmidt D, and Sanders-Bush E (1994) Constitutively active 5-hydroxytryptamine 2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687-11690. (Pubitemid 24196646)
5. Berg KA, Stout BD, Cropper JD, Maayani S, and Clarke WP (1999) Novel actions of inverse agonists on 5-HT2C receptor systems. Mol Pharmacol 55:863-872. (Pubitemid 29214606)
6. Bond RA and Ijzerman AP (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92-96.
7. Browne RG and Ho BT (1975) Role of serotonin in the discriminative stimulus properties of mescaline. Pharmacol Biochem Behav 3:429-435.
8. Costa T and Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci U S A 86:7321-7325. (Pubitemid 19254452)
9. Dekeyne A, Iob L, Hautefaye P, and Millan MJ (2002) The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats. Neuropsychopharmacology 26:552-556. (Pubitemid 34261005)
10. Dekeyne A, Iob L, and Millan MJ (2003) Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907. Neuropharmacology 44:604-615. (Pubitemid 36369140)
11. 2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology (Berl) 121:364-372.
12. Glennon RA, Young R, and Rosecrans JA (1982) Discriminative stimulus properties of DOM and several molecular modifications. Pharmacol Biochem Behav 16:553-556.
13. Glennon RA, Young R, and Rosecrans JA (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91:189-196.
14. Harvey JA (2003) Role of the serotonin 5-HT(2A) receptor in learning. Learn Mem 10:355-362.
15. Harvey JA, Welsh SE, Hood H, and Romano AG (1999) Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism. Psychopharmacology (Berl) 141:162-168. (Pubitemid 29200167)
16. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463. (Pubitemid 126782561)
17. 2A agonist activity. Behav Pharmacol 18:283-288.
18. Li JX, Rice KC, and France CP (2008) Discriminative stimulus effects of 1-(2,5- dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rhesus monkeys. J Pharmacol Exp Ther 324:827-833. (Pubitemid 351185829)
19. Negus SS (2006) Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists. Biochem Pharmacol 71:1663-1670.
20. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, and Sanders-Bush E (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472-9478. (Pubitemid 129517919)
21. Orallo F, Rosa E, García-Ferreiro T, Campos-Toimil M, Cadavid MI, and Loza MI (2000) Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro. Gen Pharmacol 35:95-105. (Pubitemid 33052469)
22. Parra S and Bond RA (2007) Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr Opin Pharmacol 7:146-150. (Pubitemid 46414176)
23. Prinssen EP, Assié MB, Koek W, and Kleven MS (2002) Depletion of 5-HT disrupts prepulse inhibition in rats: dependence on the magnitude of depletion, and reversal by a 5-HT precursor. Neuropsychopharmacology 26:340-347. (Pubitemid 34159211)
24. Romano AG, Bormann NM, and Harvey JA (1991) A unique enhancement of associative learning produced by methylenedioxyamphetamine. Behav Pharmacol 2:225-231.
25. 2A antagonist mianserin on associative learning and performance in the rabbit. Pharmacol Biochem Behav 67:103-110.
26. 2A receptor in vivo. Psychopharmacology 184:173-181.
27. Schlag BD, Lou Z, Fennell M, and Dunlop J (2004) Ligand dependency of 5-hydroxytryptamine 2C receptor internalization. J Pharmacol Exp Ther 310:865-870. (Pubitemid 39108905)
28. Schreiber R, Brocco M, and Millan MJ (1994) Blockade of the discriminative stimuluseffects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99-102.
29. Silverman PB and Ho BT (1980) The discriminative stimulus properties of 2,5- dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine. Psychopharmacology (Berl) 68:209-215.
30. Smith RL, Barrett RJ, and Sanders-Bush E (1995) Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. J Pharmacol Exp Ther 275:1050-1057.
31. Smith RL, Gresch PJ, Barrett RJ, and Sanders-Bush E (2002) Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. Pharmacol Biochem Behav 72:77-85.
32. Strange PG (2000) Agonist binding to G-protein coupled receptors. Br J Pharmacol 129:820-821. (Pubitemid 30153866)
33. 11C]labeled PET ligands. Bioorg Med Chem 8:2427-2432.
34. Walker EA, Kohut SJ, Hass RW, Brown EK Jr, Prabandham A, and Lefever T (2005) Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology 49:1210-1219. (Pubitemid 41608645)
35. Weiner DM, Burstein ES, Nash N, Croston GE, Currier EA, Vanover KE, Harvey SC, Donohue E, Hansen HC, Andersson CM, et al. (2001) 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics J Pharmacol Exp Ther 299:268-276. (Pubitemid 32905144)
36. 2A/2C antagonists on associative learning in the rabbit. Psychopharmacology (Berl) 137:157-163.
37. White FJ, Simmons MA, West KB, Holohean AM, and Appel JB (1980) The effect of serotonin depletion on the discriminability of LSD. Pharmacol Biochem Behav 13:569-574.